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Introduction
Bovine respiratory disease
Bovine respiratory disease (BRD) i an important di ease of cattle, and an
estimated $3 billion is spent annually for its prevention and treatment l•2, Although it has
been extensively investigated in recent years, BRD remains a major cau e of economic
loss in cattle in US.
BRD is caused by a variety of viral and bacterial agents4 , Pasteurella hemolytica
and Pasteurella multocida are bacteria frequently isolated from BRD case 2,3, These
bacteria are commonly found in the nasopharyngeal area of healthy animals2. Although
the bacteria cannot enter the lower respiratory tract and cause pneumonia under normal
conditions, a relatively small number of bacteria leads to severe pneumonia under certain
predisposing conditions; these include presence of a respiratory viral infection and/or
stresses brought about by climatic, nutritional changes, shipment, overcrowding, and/or
weaning2.3. Viruses commonly implicated in BRn are bovine herpe viru typ s I (BHV-
I) and BHV-3, bovine viral diarrhea virus (BVDV), bovine parainfluenza 3 (PI-3) virus,
and bovine respi ratory syncytial virus (BRSV) I, Other viru es Ie s frequently associated
with BRD include bovine adenovirus, bovine rhinovirus, bovine coronavirus, bovine
reovirus, bovine enterovirus, alcelaphine herpesvirus- I, BHV-4, and BHV_5 1.3,5,6,7,8.
Various factors must therefore be present to cause BRD and it is believed that virus
infection, stresses, and immunosuppressive agents lead to bacterial pneumonia.
Bovine herpes virus
BHV- I belongs to the virus fami Iy of Herpesviridae and subfamily of
Alphaherpesvirinae l7 ,22,29. Herpes virus is spherical or pleomorphic with diameter of 150-
200 nm and consists of an envelope and an icosahedral cap id29. Th length of BHV-I
DNA is 135 kilobase pair (kb) 4,42. The viral genome i a lil1ear double tranded DNA
subdivided into a long segment (106 kb) and a short segment (10 kb) flanked by internal
and terminal inverted repeats (II kb each) 16,18. Following ad orption to a ho t celJ
receptor via the peplomers of the envelope, the nucleocapsid penetrate by fu ion or
phagocytosis11. Replication occurs in the nucleus and BHV-1 vim acquires an envelope
by budding through nuclear membranell . BHV-l causes re piratory and reproductive
disorders leading to infectious bovine rhinotracheitis/pustular vulvovaginitis in cattle and
abortion4,19. This virus causes inflammatory and necrotizing lesion in the upper
respiratory tract, trachea, and conjunctiva3. To control viral infection, vaccination is used.
Modified live vaccine (MLV) is useful against BHV-l, and it starts to protect the cattle
48 hours after vaccination2. MLV may be used safely, but it is difficult to administer
because of post-vaccinal disease, which can occur if the vaccine virus regains
virulence2.39 . Killed vaccine is also available, but it is exp n ive and take longer to
initiate the protection, and has a shorter protection period of about a year. So, u e of
killed vaccine is not common for protection against BHV_1 2.
Bovine viral diarrhea virus
BVDV is a single-stranded linear RNA virus of the Pestivirus genus within the
family Flaviviridae9- II ,I3. It is a small (50 nm) spherical icosahedral capsid with
enveloped virus and the genome is positive sense J3,28. The length of BVDV RNA is 12.3
kb. BVDV is slightly AT rich, and has one long ORF 3898 codons long starting from nl
386. BVDV also has several very short ORFs « 30 nt) 10. Two types of BVDV (type 1
and 2) are identified. BVDV enters cells by receptor-mediated endocytosis that delivers
-the viral genome to the cyto 0110. Replication occur in cyto 01 th mbly of BVDV
takes place in the ER and Golgi, and then BVDV acquires an envelope in the lumen of
the vesicular compartment lO . This viru is a common pathogen of calv . Its immuno-
suppressive ability20. BVDV is consequently associated with a poradicallyoccurring,
highly fatal, and enteric disease that is termed mucosal di ea e9. In£. ction during
pregnancy can result in abortion, ter~togenic defect , or birth of per i tently infected
animals. Persistently infected animals erve to spread BVDV in the herdl5 . Sometime
bovine fetal serum from persistently infected calves contaminate cell culture for years
without detectable alteration of cell physiology and metabolism 10. There are 140 licen ed
BVDV vaccines in the US. Since live vaccine and killed vaccine require at least 3 weeks
and 4 weeks after vaccination to take effect, respectively4, it is necessary to identify the
virus infecting the cattle at an early stage before the infection extends to the entire herd.
There is evidence that vaccination does not fully protect against BVDV4. There is the
need, therefore, to quickly identify the BVDV infection and i olate the infected bovine
from the herd.
Diagnostic methods
The common methods to diagnose BHV-l and BVDV viral infection are virus
isolation in cell culture, immunofluorescent antibody tests (IFA), necropsy, and serologic
tests 17•21 . However, those tests present some disadvantages. Vim isolation tests are not
very sensitive because some viruses grow with difficulty, and the tests may take 1 to 3
weeks to complete17 . Virus identification by serology and necropsy methods require
either recovery or fatality of a bovine. This delays initiation of the treatment for other
cattle in the herd to avoid infection by these viruses. lmmunoperoxidase plate assay for
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-diagnosis of BVDV can handle large number of sample imultan. u ly, but thi m thad
also takes 5 to 7 working days to complete12.
It is important to identify viruses infecting cattle quickly and aecurat Iy, ince
diagnosis early in the course of infection makes it po ibJe to choo the right nutrition,
treatments (such as isolation of infected animals), and medication ( uch as vaccination).
Speedy and accurate diagnosis of BRD is essential for irnm mate action again t BRD
virus infection.
Real-time peR
Currently two commercial systems for real-time PCR are available. They are the
ABI PRISM 7700 Sequence Detection System (Perkin~Elmer, Foster city, CA) and the
LightCycler (Roche, Indianapolis, IN). Real-time PCR made quantitative PCR faster and
it also reduces the chance of contamination46-49.
A f1uorogenic probe is prepared to be specific to an internal region of the P R
product and s labeled with a reporter fluorescent dye [PAM (6-carboxy-f1uore cein)] at
the 5' end and a quencher fluore cent dye [TAMRA (6-carboxy-tetramethyl-rhodamine)]
at the 3' end46-49 . When the probe is intact, fluorescent energy transfer occurs and the
reporter dye emis ion is absorbed by the quencher dye. During the extension phase of
peR, a f1uorogenic probe is cleaved by the 5' nuclease activity of the DNA polymerase,
separating the reporter dye from the quencher dye and generating a sequence- pecific
signal (518 nm in peak fluorescent emission) 48. With each cycle, additional reporter dye
molecules are cleaved from their respective probes. The fluorescence intensity is
monitored during the PCR49 .
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-The real-time PCR system u es p cially de igned reaction tub that rem .n
closed throughout the PCR amplification and detection proce ,reducing the chance of
contamination49 . Results are available one minute after completion of thermal cycling49
and the whole process is done in 30 minute 47 to one hour46 . Portable battery-power d
devices can be used46 and the real-time PCR is the most possible method to be automated.
Since the real-time PCR is PCR primers with fluorogenic probe, it is necessary to
establish multiplex PCR conditions to u e real-time PCR for the detection of two viruse
or more, simultaneously.
Multiplex PCR
Multiplex PCR is used for simultaneous amplification of two or more DNA
fragments in the same reaction23,24, and is used for DNA testing, including analy es of
deletions, mutations and polymorphisms23 . The multiplex PCR is one assay that can be
used to diagnose viruses causing BRD. As compared to single template peR, multiplex
PCR can reduce the total number of tubes, the co t for the reagents, and po ible
contamination24 .
The first single template PCR for BVDV and BHV-l were de cribed in 199043
and 199345 , respectively. No multiplex PCR related to BHV-1 has been described thu
far, but several were published for BVDV; two were for distingui hing among border
disease virus (BDV), BVDV-I, and BVDV_225-27 . One of them also distinguished hog
cholera virus26 from BVDV. Those studies succeeded in diagnosing BDV and BVDV in
multiplex PCR without RNA extraction25,26, This multiplex PCR without RNA extraction
made it possible to diagnose the infection about 8 hours after blood collection26 .
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-However, multiplex PCR is not uitable to diagno e all viru cau ing BRD
because at Least 13 viruses are known to cau e BRD. Multipl peR und r th e
conditions is expected to be difficult due to three reasons. Fir tIy, omp tition among the
multiplex PCR products makes it difficult to amplify viru e which are pli sent in mall
amounts in the sample or have Low amplification efficiency during PCR32•33 . Secondly,
separation and identification of PCR products by size by gel electrophore is will b
difficult. This is because there are at least 13 fragment sizes to identify on the gel. The
need to identify the fragment sizes put restrictions on the primer de ign. Thirdly, primer-
dimers and primer-artifacts will be a problem32• It is possible that those products might
interact with PCR products and make PCR products of unexpected izes.
Microarray technology
The most commonly used microarray technique is that in which a microscopic
array of cDNA molecules is immobilized on olid urface (i.e. nylon, nitrocellulo , and
glass) as hybridization targets for biochemical analy is I4•5o. The array of cDNAs i printed
on solid surfaces as targets and the mRNAs are enzymatically fluore cently labeled as
cDNA probes. These cDNAs are hybridized on the microarray and un-incorporated
labeled probes are washed away. Thus, fluorescentJy labeled targets which are
complementary to targets are bound to targets. The fluorescence is detected by confocal
laser scanning and charge-coupled device (CCD) imaging l4,5o. Thi method was
developed for accurate measurement of the expression of the corresponding genes50.
Array densities are 400 to 250,000 cDNAs per cm2• This allows quantitative e timation of
the expression of many genes in one single hybridization 14. GSI Lumonics, Watertown,
CA (a maker of rnicroarray scanning device) developed a four-color fluorescence
-detection scheme, which allows up to four kind of prob to b u ed in on pre Ion
analysis. Today, fluorescently labeled DNA or RNA from biological ourc i u d a
probe and a complementary sequence is used as target l4. The application of microarray
have been extend to expression analysis, polymorphi m detection, DNA re equencing,
and genotyping on a genome scalel4 .
Affymetrix, Santa Clara, CA developed on-chip photolithographic ynthesi ,
GeneChip technology51 . It can make miniaturized, high-den ity array of oligonucleotide
probes by light-directed chemical synthesis51 • First, the protecting groups are removed
and generate free hydroxyl groups at positions illuminated by UV light passing through
the photolithographic mask. Then, 5' -protected phosphoramidite is added to deprotected
sites, and oligonucleotides are synthesized by repeating this proces 52.
In this project, I have attempted to devise a fast and simple diagno is method for
clinical users. Fast diagnosis of bovine respiratory di ease is es ential to control and
prevent infection of other bovines 12. By knowing the virus or vim es in£ cling the cattle,
the rancher can decide to isolate the infected individual or vaccinat the whole herd to
prevent infection to others. High sensitivity and a rapid procedure are required to achieve
this purpose. Further, the method of diagnosis must be user friendly. At least 13 viruse'
cause bovine respiratory disease and it will be useful if a single PCR can detect all BRD
viruses. In this research, I attempted to develop a method for the simultaneous detection
of BHV and BVDV by microarray technique and PCR. Fir t, I attempted multiplex PCR
to diagnose the virus infections of BRD. Next, I attempted to develop a ViSA (Virus
Signature Amplification) card method and a ViSH (Virus Signature Hybridization) chip
method. Both methods are based on microarray technologies and they have the potential
7
rto provide simultaneous diagno is of tbou and of vim e . Mo aic Technologi ,Inc. i
also working with Bridge amplification technologie which are imilar to ViSA card
method.
Bridge amplification technologies
Mosaic Technologies, Inc. has devised bridge amplification technology3o.32. They
immobilized acrylamide-modified oligonucleotide on many kinds of media (i.e. nylon
beads, optical fibers, and glass plates) and performed immobilized PCR. The "Bridge" of
bridge amplification technologies comes from the shape when the extension product from
one primer binds to another primer during the annealing step32. Many primer et are
placed on the media separately. This procedure should make it pos ible to diagnose ten
to hundreds of individual amplification reactions in a single reaction mixture and ve sel32.
The Mosaic Technologies' primer attachment method is co-polymerization of
acrylamide-modified oligonucleotide into a polyacrylamide co-polymer31 . The benefit of
this method is that it can avoid cross-contamination from amplified products since II
amplified products are bound to the media. Thi system will be ea ier to automate and the
use of real-time PCR is possible. Furthermore, thi method co ts less than a single
template PCR for each primer since it can test many primers in a single a ay 32.
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-Materials and Methods
Reagents
KlenTaq, wild-type Taq DNA polymerase mi ing an N-terminal portion44, and
PC2 buffer (50 mM Tris-Hel pH 9.1,16 mM ammonium sulfate, 3.5 mM MgCh, and
150 Ilglml BSA) were purchased from Ab Peptides, Inc., St. Loui ,MO. F1uoroLink Cy3-
dUTP and Cy5-dCTP (S-Amino-propargyl-2'-deoxycytidine 5'-triphosphate coupled to
Cy3 or Cy5 florescent dye) in 10 mM phosphate buffer, pH 7.0 was purchased from
Amersham Pharmacia Biotech, Arlington Heights, a. Digoxigenin-3-0-succinyl-
aminocaproyl-[5-(3-aminoallyl)-2' -deoxyuridine-5' -triphosphate] tetralithium salt (DIG-
dUTP), CSPD Ready-to-use (chemiluminescent substrate), Blocking reagent, and alkaline
phosphatase conjugated anti-digoxigenin (Anti-DIG-AP conjugate) were purchased from
Boehringer Mannheim, Indianapolis, IN. Taq DNA polymerase in Buffer B, lOx PCR
buffer, and 10 mM MgCh was purchased from Promega, Madison, WI. lOx PCR buffer
contains 10 mM Tris-HCI, 50 mM KCI, and 0.1 % Triton X-lOO. AP buffer con i ted of
100 mM Tris-HCl, pH 9.5, 100 mM NaCl, and 100 mM MgCh. Sodium borohydride
solution was purchased from Fisher Scientific, Pittsburgh, PA. Maleate buffer con i ted
of 100 rnM maleic acid, pH 7.5, and 150 mM NaCl. 20x SSC consi ted of 3 M NaCI and
0.3 M sodium citrate. Stop reagent consisted of 50% glycerol, 10 mM EDTA, pH 8.0, and
0.025% bromphenol blue.
Materials
Nylon membrane (Hybond-N, 0.45 micron, 137 mm) was also purchased from
Amersham Pharmacia Biotech, Arlington Heights, IL. Silylated glass plates (cat.# CSS-
100) were purchased from CEL Associates, Inc., Houston, TX. PCR select-II and III were
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-purchased from 5 prime-3 prime, Inc., BouJder, CO. GeneAmp RNA PCR kit
containing MuLV reverse tran criptase, RNa e inhibitor, and random hexamer were
purchased from Perkin Elmer, Foster city, CA. 100 bp DNA ladd r wa purch d from
Life Technologies, Rockville, MD. Frame-Seal incubation chamber for ealing reactions
on slides were purcha ed from MJ Research, Inc., Watertown, MA. Array it UniHyb wa
purchased from Telechem International, Sunnyvale, CA. Array it Hybridization cas ette
was also a product of Telechem International, and was kindly provided by Dr. Cu hman.
Machines
ScanArray 3000 (GSI Lumonics, Watertown, CA), also provided by Dr. Cushman
was used to scan the slides. PCR cyclers were PTC-lOO made by MJ research, Inc. PCR
cycler for slides was provided by Dr. Verchot, Department of Entomology and Plant
Pathology. UV cross-linking was performed in a Stratalinker (Stratagene, La Jolla, CA).
Vacuum oven was GP I00 115 made by Savant, Farmingdale, NY. for the vacuum part
and model 5831 made by Napco, Tualatin, OR. for the oven part. Speed Vac (sell OA)
was made by Savant. Gel Doc 1000 was made by Bio-Rad, Hercules, CA. HL-4 rotor of a
GLC-2 centrifuge was made by Kendoro laboratory products, Newtown, CT.
Templates
All templates were provided by Dr. d'Offay. BHV wa propagated from clinical
tissue samples in primary bovine fetal kidney cells and in Madin Darby bovine kidney
cells (MDBK) 41. Then, DNA was extracted from infected MDBK cells and purified by
ethidium bromide-sodium iodide equilibrium gradient centrifugation41 . DNA-containing
10
-gradient fractions were dialyzed again t TE buffi r (10 mM Tri , 1 rnM EDTA), thanol
precipitated, and resu pended in TE buffer41 ,
To isolate BVDV, supernatant fluid from BVDV infected c Jl wa mix d with
guanidine isothiocyanate lysis buffer, sodium acetate, phenol, and chloroform27 , Then, the
mixture was centrifuged and the aqueous phase precipitated with i opropanol. The
resultant precipitate was washed with ethanol and dis olved in water27 •
Primers
Pairs of primers are required for each amplification of viral nucleic acid by peR.
Table I lists primers used for each amplification in this project.
Table 1 primers
Virus Primer Primer sequence (5' -3') Genome
position
BHV-l 766 (T)CAACCTCGTCGTGTGCACCCTC (22 bp) 63775-63796
InBHVI TAGACCCCAGTTGTGATGAATGC (23 bp) 63994-64015
665 TAGAGCTCGCGGCACITGAGCG (22 bp) 64059-64080
BHV-2 4109 (T)GCGGCGGCGGAGTCTGGCTITGAGG (24 bp) 2416-2439
InBHV2 TACCAGAAGTCCGACAAG (18bp) 2569-2586
4110 TCGCTGATGTTGTTCGGAGGGAGGTTGA(28bp) 2810-2837
BRD and PI TAACAAACATGGTTGGTGCAACTGGT (26 bp) 1424-1449
BVDV lSI P2 (T)CTTACACAGACATATITGCCTACGTTCCA (29 bp) 2221-2250
amplification
BRD 20d TSI TATATTATITGGAGACAGTGAATGTAGTAGCT (32 bp) 1684-1716
amplification P2 (T)CTTACACAGACATATITGCCTACGTTCCA(29bp) 2221-2250
BVDV-22M TS2 TGGTTAGGGAAGCAAITAGG (20bp) 1802-1821
amplification P2 (T)CTTACACAGACATATITGCCTACGTTCCA (29 bp) 2221-2250
BVDV-I2oa TS3 TGGGGGTCACTIGTCGGAGG (20bp) 2027-2045
amplification P2 (T)CTTACACAGACATATITGCCTACGITCCA (29 bp) 2221-2250
Note: (T) denotes an additional T added when 5' amino-linked oligonucleotides were
made.
II
-Two 22 bp primers, 665 and 766, were designed by Ely R.W. et aI. from a
conserved region of publIshed nucleotide equences of BHV-1 thymidine kin 5g n
Sullivan, D. G. et aI designed PI and P2 to share maximum homology with BVDV-I,
BVDV-2, and border disease virus (BDY). They de igned type p cific prim r TS I,
TS2, and TS3 to anneal specifically to BDV, BVDV-2, and BVDV-l re p ctivell7.
InBHVI and InBHV5 were designed by Kibenge F. S. B. et al4o. Primer 4109, 4110, and
InBHV2 were designed by Dr. d'Offay from the sequence ofBHV-2 (unpubli hed).
BVDV
7'
Pl=*
i
826 bp
TS2
~
P2
.-
448 bp P2
....
~3 223 bp P2
i ,
....
Fig. 1 Diagram of BVDV specific primers
Nested peR for BVDV
BVDV amplification was performed by nested PCR. Since BVDV is an RNA-
containing virus, reverse transcription (RT) is carried out first. Next, the first PCR was
performed to amplify all types of BVDVs, and then the second (ne ted) PCR was done
using the diluted first peR product as template to amplify specific types of BVDV .
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-Detection of soluble peR products by agarose gel electrophoresis
Soluble peR products were analyzed by agaro e gel el ctrophor i. 1.0 and 1.5
% agarose gels for electrophoresis contained 0.5 mg/ml ethidum bromide for detection of
DNA. Samples loaded consisted of 5 ~L peR product, 4 ~L stop reag nt, and 10 ilL
ddH20. 100 bp ladder was used to determine product sizes. DNA wa detected by Gel-
Doc 1000.
Invariant conditions for peR
Unless mentioned otherwise, I used the following condition . The volume of PCR
mixture was 50 ilL total in most soluble PCR experiments but for the experiment using
Cy5 the volume was 25 ~L total.
Specific for BHV amplification
PCR mixture consisted of 2.5 u Tag DNA polymerase, 1 ~L each of L mg/mL 665
and 766 primer (Table 1), Ix PCR buffer, 2 % DMSO, 1.5 mM MgCI 2, and 0.2 mM
dNTP. PCR cycle wa 94°C for 3 minutes followed by 40 cycle of 94 °c, 68°C, and 72
°C for 1 minute each, and then, 72°C for 10 minut~ .
Specific for BVDV amplification
First, reverse transcription CRT) was performed. The conditions for RT were 25 u
MuLV reverse transcriptase, RNase Inhibitor lOu, 1 ilL of I mg/mL P2 primer, and 0.32
mM dNTP with total 10 ilL. This mixture was heated to 42°C for 15 minutes, and 99 °C
for 5 minutes, then cooled to 4°C for 5 minutes.
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Next, the first PCR was perform d. PCR mixture can i ted of 10 IJL of RT
mixture, 2.5 u Taq DNA polymerase, 1 J1L of 1 mg/mL PI primer, 1 PCR buff r, 1.5
mM MgCh, and 0.2 mM dNTP. peR cycle was 94°C for 2 minute foUowed by 35
cycles of 94°C, 55 °c, and 72°C for 1 minute each, and then 72 °c for 10 minut .
Then, the second PCR (nested PCR) was performed. PCR mixture can i t d of I
IJL of I:500 diluted 1st PCR mixture, 2.5 u Taq DNA pol'yrnera e, I ilL each of 1 mg/mL
TS 1, TS2, TS3, and P2 primer, 1x PCR buffer, 1.5 mM MgCl2, and 0.2 mM dNTP. PCR
cycle was 94°C for 2 minutes followed by 30 cycles of 94 °c, 50°C, and 72 °C for I
minute each, and then, 72°C for 10 minutes.
ViSA card method and ViSH chip method
ViSA card method used PCR amplification on the primer-attached media, uch as
nylon membranes or glass slide. One set of primers needed for PCR amplification are
mixed and spotted on the media. At the denaturing temperature (about 94°C) of P R
cycle, templates are denatured and separated into two strands. Then, at the ann aling
temperature (about 50 °C), templates attach onto primers complementary to the template.
Next, at the extension temperature (72 °C), PCR products, which are complementary to
templates, are made by polymerase activity. By repeating this cycle, primers, attached on
the media, change into PCR products.
ViSH chip method uses hybridization on the primer-attached media. Each primer,
which is complementary to the peR products, is spotted separately on the media. PCR
products are hybridized with complementary primers onto the media.
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Attachment of primers on a nylon membrane
0.2 ~L of 10 mglmL mixed primers were potted on a nylon m mbran and
treated with 120.0 mJ UV by UV c[1Qsslinker. (Alternatively a vacuum oven was u ed
with for 4 hours at 80°C). Then, the nylon membrane was washed with 0.2% SDS and
0.2x SSC solution for 10 minutes twice, and with 0.2x SSC olution for 10 minute four
times. This nylon membrane was used for PCR immediately after the wa hing tep .
Attachment of primers on a silylated glass slide
0.5 ~L of 20x SSC was added to 4.50 ~L of mixed primer, and the mixture was
spotted on a silylated glass slide. This slide was dehydrated for at I.east 4 hours, then
washed with 0.2% SDS solution for I minute and with ddH20 for 1 minute twice. Next, it
was incubated in sodium borohydride solution for 5 minutes, and washed with 0.2% SDS
solution for I minute and with ddH20 for 1 minute twice. This slide was kept in the dark
and room temperature unti I u ed.
DIG or Cy labeled PCR product
DIG labeled product was produced from 0.7 mM DIG-dUTP under the PCR
conditions mentioned above. Cy labeled product was produced from 1 mM Cy3 dUTP or
Cy5 dCTP in the PCR conditions mentioned above.
A detection method for DIG
Nylon membranes or glass slides were washed in 2x SSC and 0.2% SDS solution
for 5 minutes twice and in 0.2x SSC solution for 15 minutes twice. Then, they were
neutralized in maleic buffer for 5 minutes and in 1% blocking buffer for 30 minutes.
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Next, they were incubated in 1:5000 Anti-D G-AP conjugate in 1% blocking buffi r for
30 minutes, and washed in maleic buffer for IS minutes twice and in AP buffer for 2
minutes. At last, binding of conjugate was detected by X-ray film using
chemiluminescent substrate according to manufacturer's instruction.
PCR product attachment and detection method for Cy3 and Cy5
peR in Frame-Seal
Two Frame-Seals were applied to make spaces to apply the peR mixture on a
primer-attached slide, and this slide was kept at room temperature over night. Then, a 25
~L of PCR mixture, which was mentioned above but without primer , was appl ied to the
Frame-Seal chambers and sealed by a plastic sheet supplied with Frame-Seal. Next, the
slide was placed on a thermal cycler.,
Hybridization in Frame-Seal
One or two Frame-Seals were applied on a primer-attached Iide, and thi lide
was kept at room temperature overnight. Then, hybridization solution can i ting of one
volume of PCR product and four volumes of UniHyb hybridization solution was applied
on this slide, covered by a Frame-Seal sheet and kept in an oven at 50 DC or 68 DC for 4
hours.
Hybridization in the hybridization cassette
1.25 ~L of hybridization solution (one volume of PCR product and four volumes
of UniHyb hybridization solution) per I cm2 of glass cover area was applied on gla
cover and this glass cover was placed on the primer-attached slide in a Hybridization
If)
cassette with 5 ilL hybridization solution for humidity. Thi c ette w pI d'in a
heated water bath for 4 hours.
Detection methodfor fluorescence
Glass slides were washed in 2xSSC and 0.2% SDS solution for 5 minutes and in
0.05xSSC solution for I minute. Then, they were dried by spinning at 500 to 1000 rpm in
a HL-4 rotor of a GLC-2 centrifuge. Presence of Cy3 and Cy5 was determined by
Scanarray 3000.
peR select II and III
PCR select-II or ill was used to remove unincorporated dNTPs, primers, and
primer-dimers. PCR select-II was used to remove up to a 100 bp product, and PCR select-
ill was used to remove up to a 300 bp product. 5 ilL of PCR product was taken from tube
and diluted to 50 ilL with ddH20. PCR select-II or ill column wa invert d veral time
to resuspend gel, and centrifuged at 1000xg for 1 minute using a HL-4 rotor of a GL -2
centrifuge. The collection tube was emptied and the column was centrifuged at 1000 xg
for 5 minutes. Then, the collection tube wa discarded, 50 ilL of diluted PCR product was
applied into the column, and centrifuged at 1000xg for 3 minutes. The collected buffer
was placed in speed vac and centrifuged for 2 hours. The dried sample was mixed with 5
ilL ddH20 .
Oligonucleotide (primer) detection by YOYO-l
I JlL of 1: 1000 dilution of YOYO-l in TAE buffer (4 mM Tris-acetate, 0.1 mM
EDTA, pH 8.2) were applied to the nylon membrane on which primers were
17
-immobilized. One hour later, the nylon membrane w wa hed with wat r briefly and
dried. The hybrids of YOYO-Is and primers fluoresce yellow under UV lamp.
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-Results and Discussion
Detection of specific viruses by soluble PCR of a part of the viru genome and
analysis of the result of amplification by agaro e gel electrophore i i well established.
Thus, we started optimizing the conditions for soluble PCR for each ingle BRD vim.
This optimization process was necessary to perform multiplex PCR, which amplifi and
detects more than one virus, since each amplification had a different optimum range of
annealing temperatures, Mg++ concentrations and other conditions. It was also important
to use these data to determine conditions compatible with both amplification for u e a
starting points for the PCR conditions of ViSA cards.
Soluble PCR results
First, BHV-1 amplification was performed by the soluble PCR. PCR cycle was 94
°c for 3 minutes followed by 40 cycle of 94°C, 68 °c, and 72°C for 2 minute each, and
then, 72°C for 10 minutes (72°C for 2 minutes instead of I minute in invariant
conditions for BHV-I amplification described in Materials and Methods). At 10 %
DMSO, BHV-I amplification was detected as 302 bp DNA fragment at 1.0 and 1.5 mM
MgCh but not at 0.5 and 2.0 mM. Next, DMSO volume ratios 0, 2, 4, 6, 8, and 10 %
were tested with 5.0 u Taq DNA polymerase. Expected size DNAs were identified on the
agarose gel only from 2, 4, and 6 % DMSO PCR products. All PCR products, including
no-template control product, showed unexpected fragments of less than 100 bp ize after
gel electrophoresis. These fr.agments, often refereed to as primer-artifact or primer-
dimer36, appeared in most PCR reactions for BHV and BVDV. The primer-dimer or
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-primer-artifact i caused from self-annealing or dimerization of primer 665 and 766 in
BHV-1 amplification.
Multiplex PCR, in which more than one amplification occur imultaneou Iy in
one tube, requires one set of conditions that allow all of the de ired amplification to
occur. Thus, I tested whether BVDV was amplified in the fir t PCR at 1.5 mM MgCI2 a
concentration at which BHV was amplified (2.0 roM MgCh i a de ignated concentration
for this amplification). First, BVDV-1 first amplification was tested at 1.5 and 2.0 rnM
MgCh. Although 2.0 rnM MgCh produced a larger amount of the expected ize PCR
product, 1.5 mM MgCb was enough to identify BVDV-l amplification.
Also, BVDV-2 amplification was tested at 1.5 mM MgCh and obtained after
second amplification with 1.5 rnM MgCh. Therefore, both BHV and BVDV (including
first and second amplification of BVDV) can be amplified at 1.5 mM MgC12.
Next, I tried to amplify each virus in the same PCR conditions. BHV-l, BVDV-l,
and BVDV-2 were amplified in the fir t RT-PCR conditions for BYDY, whose ann aling
temperature was 55°C, (described in Materials and Methods) with 10 % DM O. All
tubes contained primers for BYH-I (665 and 766) and first PCR of BVDV (P I and P2).
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Fig. 2-1 Gel electrophoresis analysis of first peR amplification products formed
under identical conditions from BHV-1, BVDV-1, and BVDV-2 templates
From left, lane I: lOObp ladder. Lane 2: BHV-l. Lane 3: BVDV-] template.
Lane 4: BVDV-2 template. Lane 5: no-template control.
Fig. 2-1 shows first amplification of nested PCR results. [n this experiment, a tube
that contained BHV-I as a template showed a ligh t band of the expected BHV-I PCR
fragment size (302 hp). The faintness of the band was probably due to a difference in
optimum annealing temperatures between BHV-1 and BVDV-I amplifications. BHV-I
amplification was optimal at 68°C as an annealing temperature, but this experiment used
55 °c as an annealing temperature since BVDV amplification were optima] at 55°C for
a first amplification. The tubes containing BVDV-I and BVDV-2 did not show any
products in agarose electrophoresis after the first PCR. In most PCR, fir t amplification
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of BVDV did not produce visible amount of PCR products and PCR product w r een
after nested PCR.
Fig. 2-2 Gel electrophoresis analysis of second (nested) PCR amplification
products formed under identical conditions from BHV-I, BVDV-I, and BVDV-
2 templates
From left, lane 1: 100 bp ladder. Lane 2: BHV-1 product from first PCR (Fig. 2-
1). Lane 3: BVDV-I product from first PCR. Lane 4: BVDV-2 product from fir t
PCR. Lane 5: no-template control product from first PCR. Lane 6: no-template
control (H20).
[n Fig. 2-2, the second (nested) PCR results, PCR conditions for BVDV were u ed
with I :500 dilution products of the first PCR as template. Both a tube with BVDV-I
template and a tube with BVDV-2 template showed expected size products (224 bp and
448 bp, respectively) after agarose gel electrophoresis. This second PCR did not contain
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-DMSO and contained primers only for BVDV econd PCR (P2, TS 1, TS2, and TS ).
Thus, no amplification of BHV-1 was expected since there are no BHV-1 pecific
primers, and no BHV-I product was seen in the gel bown in Fig. 2-2.
Since I succeeded in single virus amplification ofBHV-l BVDV-I, and BVDV-2
in the same PCR conditions and reagents, I tested whether the individual reaction could
be multiplexed. BRD is often caused by two or more viru e infect d simultaneou Iy.
When two or more viruses and appropriate primers were mjxed in one tube, no or only
one virus was amplified and detected with M~ Research's thermal cycler while multiplex
PCR was successful with a thermal cycler made by Perkin Elmer. One possibly important
difference between the tW9 cycler is that for the latter a few drops of oil are added to PCR
tubes to avoid evaporation, while in the MJ Research cycler no such addition is nece sary.
In this experiment, RT was performed in RT conditions mentioned in "Materials and
Methods" with BHV-I and BVDV-2 as templates. I prepared three tubes; one BVDV-2
only template tube with only PI primer (a BVDV primer), one BHV-l only template tube
with 766 and 665 primers (BHV-I primers), and one mixture of BVDV-2 and BHV-I
templates tube with PI, 766, and 655 primers (a BVDV primer and BHV primers). First
RT-PCR was performed in BVDV RT-PCR conditions with a BVDV primer, P2, used in
RT, with 2 % DMSO. Primers PI, 766, and 665 were added after the RT reaction.
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-Fig. 3-1 Gel electrophoresi.5 analy is of first peR amplification products from
mixed BHV-I and BVDV-2 templates
From left, lane I: 100 bp ladder. Lane 2: BVDV-2 template with PI primer. Lan
3: no-template control with PI primer. Lane 4: BHV-I template with 665 and
766 primers. Lane 5: no-template control with 665 and 766 primer. Lane 6:
mixed template ofBHV-1 and BVDV-2 with PI, 665, and 766 primers. Lane 7:
no-template control with PI, 665, and 766 primers.
Fig. 3-1 shows results after the first amplification of nested PCR. An expected
size SHY-1 product (302 hp) showed up weakly on an agarose gel in the tube that
contained a mixture of BHY-1 and BYDV-2 templates while the BHY-l only tube
produced a strong 300+bp band and the BYDV-2 only tube did not produce any
detectable products. Second PCR was performed in BVDV second PCR conditions with
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P2, TS 1, TS2, and TS3 primer in all tubes and the 1:500 dilution pr duct of tb ·1 t
peR as templates.
Fig. 3-2 Gel electrophoresis analysis of second (nested) peR amplification
products from mixed BHV-l and BVDV-2 templates
From left, lane I: 100 bp ladder. Lane 2: BVDV-2 template from Fig. 3-1 lane 2.
Lane 3: no-template control from Fig. 3-1 lane 3. Lane 4: mixed templates of
BHV-I and BVDV-2 from Fig. 3-1 lane 6. Lane 5: no-template control from Fig.
3-1 lane 7. Lane 6: no-template control, H20.
Second (nested) peR, Fig. 3-2, produced two products in the tube that contained a
mixture ofBHV-l and BVDV-2 templates. One was the expected size BVDV-2 product
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-(448 bp). Another was of an unexpected size (about 200+bp). The BVDV-2 only tub
produced the expected size BVDV-2 product and the BHV-1 only tube did not produce
any detectable products. Since 200+bp band was produced only in amplification with the
mixture of BVDV-2 and BHV-l templates, this product wa probably an artifact due to
interaction of BVDV primers or template with BHV-1. This experiment and previou
experiments show that BHV-I and BVDV can be diagnosed in the arne ne ted PCR
conditions and with the same reagents.
In most PCR, less than 100 bp PCR fragments were seen on the gel. Tho e were
primer-dimers or primer-artifacts made from primer-primer interactions. Changing of
Mg++, primer, and template concentrations did not reduce those products.
Nylon membrane supported insoluble peR (ViSA card)
Multiplex peR produced an artifact and lower amplification in the soluble PCR of
the previous section because primers will interact with template and PCR product in
unintended ways if many pairs of primers are mixed. To solve this probl m, I started the
ViSA card. It is not necessary to mix many primers on the ViSA card since each p ir of
primers were spotted separately and each virus amplification occur only at a primer pot
at which both primers are complementary to the viral nucleic acid, so that we expected
more specific simultaneous amplification for many viruses. (See "Method and
Materials" section for detail.)
Either UV crosslinking or a vacuum oven was used to attach primers on nylon
membranes. These membranes, when used in PCR, could detect the presence of viral
nucleic acid (Fig. 4-1 and 4-2).
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Fig. 4-1 ViSA card detection with BVDV-2 template
Autoradiographic image of nylon membrane containing TS2 and P2 primer and
amplified in the presence (1) or absence (2) of BVDV-2 template at 0 % DMSO.
Fig. 4-1 shows a ViSA card that detected BVDV-2. In this experiment, 1~L of
lmg/ml primers for BVDV-2 second PCR was spotted on the nylon membrane and the
membrane baked for 4 hours in a vacuum oven. These nylon membrane were in erted
directly, without washing, in 0.5 mL tube and BVDV second peR mixture was added
into the tubes. One tube also received the diluted PCR product of BVDV-2 amplification.
Chemiluminescence was used for the detection (See materials and methods). The card
reacted with BVDV-2 template produced a definite spot on X-ray film after 15 minutes of
exposure to the film while the control card reacted without BVDV-2 template produced a
very faint spot. No-template controls often produced a spot. Thi indicates that DIG can
attach on the membrane directly but not with high affinity.
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Fig. 4-2 ViSA card detection with BHY-1 template
Autoradiographic image of nylon membrane containing 665 and 766 primer and
amplified in the presence (l) or absence (2) of BHV-) template at 2 % DMSO.
Fig. 4-2 shows a ViSA card produced with UV crosslinked primers. The ViSA
card with which BHV-l was used as a template clearly produced a definite spot in X-ray
film after 3 minutes exposure. The card incubated without BHV-1 template did not
produce a spot. A washing step (see Materials and Methods) before PCR was need d to
obtain this result. Without this washing step, the negative control (without template)
showed up faintly, and sometimes it was difficult to identify a difference between positive
control (with template) and negative control.
BHV amplification in soluble PCR required at least 2 % DMSO, and BVDV wa
amplified with up to IO % DMSO in soluble PCR. However, DMSO inhibited BHV-2
amplification in nylon membrane supported ViSA card.
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-ViSA card No.1 No.2 No.3 No.4
%DMSO 0% 1% 2% 0%
template + + + -
Fig. 5 BHV-2 detection on nylon membrane at various DMSO concentration
Autoradiographic image of nylon membrane containing 4109 and 4110 primers
and amplified in the presence or absence of BHV-2 template with various %
DMSO.
Fig. 5 shows the effect of DMSO in BHV-2 amplification. 0.2 JlL of I mg/ml
mixed primers, 4109 and 4110, were spotted on nylon membrane. Th peR ex.periment
was performed with 0, 1, and 2 % DMSO in each tube. ViSA card without DMSO
produced a very dark spot, whiJe that at I % DMSO produced a faint one and that at 2 %
DMSO produced almost no spot on the X-ray film after 30 minutes exposure. The no-
template control produced a spot as weak as 2 % DMSO did. Thu ,BHV-2 amplification
on the nylon membrane showed inhibition by DMSO.
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Fig. 6 BHV-1 detection on nylon membrane at various DMSO concentration
Autoradiographic image of nylon membrane containing 665 and 766 primers and
amplified in the presence or absence of BHV-1 template with various % DMSO.
Fig. 6 shows the effect of DMSO in BHV-l amplification. 0.2 ilL Mixed primers
of 1 mg/ml 665 and 766 were spotted on nylon membrane. When BHV-I wa u ed for a
template, all ViSA cards with 0, 2, and 4 % DMSO produced a spot. When no-template
control was added, no pot was seen. Immobilized BHV-l amplification howed no
inhibition. Since both BHV-l and BHV-2 show amplification without DMSO and BHV-2
shows inhibition by DMSO, it is not desirable to use DMSO in ViSA card. Moreover,
Fig. 4-1 showed the detection of BVDV-2 without DMSO. Thus, DMSO is not required
for the detection of BHV and BVDV on the ViSA card.
Spotting of 0.2 ilL of primer solution made only a small pot on the ViSA card
and did not cover all the nylon membrane even when the membrane was small. As
mentioned in "Material and Methods" section, peR products are extended from primer
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-and all primers are attached on the ViSA card. Thu , no peR product bould b u ide
of the spots made when primers were potted. However, most X-ray film how d that a
spot covered all the membrane. The pot on X-ray film is due to DIG (from DIG-dUTP
used for labeling the PCR product.) Anti-DIG-AP attache to DIG and then Anti-DIG-AP
causes a chemiluminescent reaction with other substrates. Possible explanations for the
DIG reaction product covering all the membrane are: the spotted primer diffuse from the
place of spotting to cover the whole membrane; somehow DIG became attached not only
on the primer but also on the nylon membrane directly; anti-DIG-AP attached on
something else besides DIG; and peR products were released from the membrane and
reattached at random locations. To test whether primers are removed from the nylon
membrane to produce a spot outside of where 1 mg/ml primers are spotted I used YOYO-
1 to check the primer position after spotting. YOYO-I reaction revealed a spot as small as
the place wetted after primer solution was spotted, even after washing steps. This
confirmed that the place primer attached to was the same as the place wetted during
primer spotting. However, 0.1 mg/ml primer on nylon membrane wa not detected by
YOYO-l, and I could not test whether primer was removed during the PCR cycle 'ince
YOYO-l detects the PCR products as well as the primers and PCR products are
accumulated during PCR cycle . At this point, I am not sure that primers stay at the same
position during PCR cycle or only small amounts of primers (not detectable amount by
YOYO-l) are detached and reattached around area where primer were originally
attached. The second two possibilities are probably impossible since most no-template
controls show nothing on X-ray film. If DIG or Anti-DIG can attach on nylon membrane
directly, there should have been spots on the no-template control, too. The remaining
possibility is that PCR product becomes attached on the nylon membrane directly.
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-Thus, I tested whether PCR product can attach on nylon membran without
primers. Soluble PCR was performed with BHV-I. This PCR mixture contained prim r
nylon membrane, and DIG-dUTP in the solution. The nylon membrane wa removed
from solution after the PCR cycles, washed, and allowed to expo e X-ray film as ViSA
card. A spot, which covered all the membrane, was seen without immobilized primer on
the nylon membrane. No-template control had no spot on the ViSA card. This indicated
PCR products can attach on the nylon membrane during PCR cycles and thee bond are
strong enough not to wash away during washing steps.
Although the explanation for the spot covering all the membrane is unclear, the
background problem (a dark place on X-ray film around where the primer should be)
could be controlled by changing the primer and template concentrations (Fig. 7 and 8).
For 30 min.
0.01 mg/rnl primer
1 mg/rnl primers
For II min.
I mg/ml primers
•t)
It
•
«
a
No pt:imers No-template
Fig. 7 BHV-2 detection by ViSA card using different primer concentrations
Autoradiographic image of nylon membrane containing 4109 and 4110 primers
and amplified in the presence or absence of BHV-2 template with various primer
concentrations. The picture on the left shows the image after 30 minutes
exposure. Right one shows the image afterl) minutes exposure.
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-Fig. 7 shows the effect of dilution of primer on BHV-2 amplification. Th fir t
membrane (Fig. 7, no-primers) had no primer potted and was ubmitted to ampljfi ation
with non-diluted BHV-2 template. The second membrane (Fig. 7 1 mg/ml prim r
which received I mg/ml primers (4109 and 4110), and the third m mbran (Fig. 7 0.01
mg/ml primers), which received 0.01 mg/rnl primer weT amplifi d with 1: 0 diluted
BHV-2 template. The fourth membrane had 0.01 mg/ml primer and wa ubject d to
PCR without BHV-2 template (Fig. 7, no-template). After 11 minute of expo ur t· X-
ray film, the membrane with 1 mg/ml primers produced a pot in the center of ViSA card
and other ViSA cards did not produce a clear image. After 30 minutes, the membrane
with 0.0 I mglml primers produced a spot in the center of ViSA card, too. These pots (I
mg/ml and 0.01 mg/ml) were in places primers were spotted. No-template control weakly
darkened the film all over the membranes. No-primer control clearly showed up and was
weaker than membrane with 0.0 I mg/ml primer. This was an unexpected result which has
two possible explanations. One was the unbalanced distribution of chemiluminesc fit
substrate. Because X-film exposure was long (30 minutes), the substrate dried up on the
other membranes and it did not on the no-primer control. Thus, it became darker than no-
template control. Another possible explanation is due to non-specific attachment of
labeled template. As I mentioned above, labeled PCR product could attach on the
membrane directly. The no-primer control can not produce the PCR product but it
probably produced labeled template during the PCR cycles. Then, the labeled template
attached on the membrane directly.
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Fig. 8 Detection of diluted BHY-I
(Top) Gel electrophoresis result of diluted BHY-I peR results. From left, lanel:
100 bp ladder. Lane 2: original BHY-I. Lane 3: I: 10 diluted BHY-I. Lane 4:
1: 100 diluted BHV-1. Lane 5: no-template control.
(Bottom) Autoradiographic image of nylon membrane containing 665 and 766
primers and amplified in the presence or ab ence of BHY-1 template wi th
various template concentrations. Arrow marks position of a darker spot in the
center of strip.
Nylon membrane supported ViSA cards showed a higher sensitivity than soluble
PCR (Fig. 8). Reactions used BHV-1 for a template. 0.1 JlL 1 mg/ml primers (665 and
766) were spotted on nylon membrane and UV-crosslinked. Soluble PCR was te ted
under the same PCR conditions except for addition of primers. When soluble and ViSA
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-card peR were performed with a series of diluted template , (no dilution :10 dilu ion,
and 1: 100 dilution), all dilutions produced spots in ViSA cards but oluble peR pr duc d
a detectable band in agarose gel only at no and] :10 dilution, but it did not at 1: 100
dilution. On the other hand, 1: 100 diluted BHV-1 template produced a pot in the ar a
where the primers were actually spotted while higher concentration produced a mor
disseminated reaction (Fig. 8 top). Thus, these results showed higher ensitivity of ViSA
card and the importance to control primer and template concentrations in performing
multiplex peR on the nylon membrane based ViSA card to identify which primer pair
reacted to the viruses.
A B
4109 and 4] 10
P2 and TS2
t t t t
Sample No-template BVDV-2 BHV-2 Mixed
control template template template
Fig. 9 Multiplex immobilized peR on ViSA card (nylon membrane)
A is a diagram of placement of primer pairs on the card. B is autoradiographic
image of nylon membrane containing primers as described in A and amplified in
the presence or absence ofBHV-2 and BVDV-2 template.
Fig. 9 shows a multiplex peR result with BHV-2 and BVDV-2. On the bottom
half of nylon membranes 1 mglml mixed primers for BVDV-2 (P2 and TS2) were spotted
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and 1 mg/ml primers for BHV-2 (4109 and 41 JO) were spotted on the top half. B h PCR
tube contained one ViSA card and the peR mixture with DIG-dUTP. One tube contained
two templates (BHV-2 and BVDV-2). A pair of tubes contained one or th other
template. The final tube contained no-template. BVDV-2 template was a 1:500 dilution of
first amplification product in soluble PCR. After 7 minutes of expo ure to X-ray film,
ViSA card with two templates produced two spot, one for each primer pair spotted,
while those with one template produced one spot at the appropriate place and the one
with no-template did not produce any spots.
Silylated glass plate supported ViSA card and ViSH chip results
A ViSA card is a nylon membrane or glass plate on which primers are
immobilized and PCR is performed. Since all PCR primers are on the card, all PCR
products will be attached on a ViSA card. A ViSH chip is a glass plate on which
oligonucleotides are immobilized to serve as hybridization target for PCR. PCR pr duct
for ViSH chip are prepared separately in soluble PCR.
ViSA card results
First, DIG-anti DIG detection was used with silylated glass plate ViSA cards. Fig.
10 shows two slides with 0.5 IJL of 10 mg/ml primers, P2 and TS2, that were amplified
with and without 1:500 dilution of first BVDV-2 PCR products as template. The card
with the template produced weak but darker spots than the one without template on the
X-ray film. This result suggested that amplification of BVDV-2 occurred. However, it
was not easy to identify the difference between with and without the template and it took
too long to obtain a result since the amplification with DIG was weak and required about
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-6 hours of exposure to X-ray film. Since DIG label did not inhibit th ampli i
the soluble PCR and nylon membrane supported ViSA card, the det ction of
amplification must have been poor due to the use of the silylated glas lide.
Fig. 10 Detection of BVDV-2 by ViSA card (gla s slide)
Autoradiographic image of gLass lide containing P2 and TS2 primers and
amplified in the presence or absence of BVDV-2 template. Arrow marks position
of primers were immobilized.
However, there was no better way to detect the tiny amount of DIG labeled PCR
product. Thus, I decided to try Cy dyes (Cy3-dUTP and Cy5-dCTP) with the ScanArray
3000. Before the ViSA card experiments with Cy dye were started, I tested whether
amplification with Cy3-dUTP required conditions in the soluble PCR which differed
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-from DIG labeled or other oluble PCR condition . Th fir BVD -2 peR rodu t was
diluted and amplified with Cy3-dUTP under second amplification c ndition of BVDV-2
including up to 4 % DMSO. When soluble PCR condi.tion but with Cy3-dUTP in t ad of
dTTP were used, PCR did not produce any products. Moreover, no amplification detected
in soluble PCR by electrophoresis of PCR products when 0.01 mM dTTP and 0.02 mM
Cy3-dUTP were used instead of 0.02 mM dTTP in BVDV-2 second amplification. PCR
produced a faint band on electrophoresis when 0.01 mM dTTP and 0.01 roM Cy3-dUTP
were used, and PCR produced a strong band when 0.02 mM dTTP and 0.01 roM Cy3-
dUTP were used. Thus, Cy3-dUTP incorporation required addition of dTTP. Till re ult
indicates that higher concentrations of Cy3-dUTP inhibit the production of PCR product.
Zhu, Z et al. (1994) explained this phenomenon by the close proximity of Cy3-
dUTPs incorporated into the PCR product in high molar ratios of Cy3-dUTP to dTTP, 0
that, in the next cycles, there is no space for the polymerase to bind, inhibiting the
formation of peR product34. I al 0 te ted the ViSA card amplification with 0.02 mM
dTTP and 0.01 mM Cy3-dUTP in BVDV-2 second amplification. No amplification was
detected by scanning the slide.
According to Voss, H. et al. (1997), Cy5 dye i incorporated les with AmpliTaq
than with Klentaq35. There were three possibilities; one was that no amplification
occurred on the silylated glass plate supported ViSA card with Cy3 label. Another wa
that PCR product was produced on the ViSA card but it could not produce a spot by
scanning since not enough Cy3 dyes were incorporated into PCR product. A third
possibility was that product was released from the slide during high temperature in PCR.
If the second one were right, Klentaq would be more likely to produce a spot detectable
by scanning. Although Klentaq is derived from Taq polymerase, KJentaq has different
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-optimal conditions from Taq polymerase. BVDV amplification with Taq polym r
required 1.5 to 2.0 mM MgCh and 1xPCR buffer, and BHV amplification required 1.0 to
1.5 roM MgCh and 1xPCR buffer. However, the amplification with Klentaq w b tt r
with no MgC12 added and lxPC2 buffer (contained a final concentration of 3.5 roM
MgCI2) than any other MgCh concentration and buffer.
Glass slides were scanned after the primer attachment proce and wa hing t p
to confinn the attachment of primers on the silylated glas plate. In this exp riment,5'
aminolink primer was spotted on the center of a silylated glass plate and non-aminolink
primer was spotted on the bottom half of the same silylated glass plate. Under the highest
sensitivity setting of ScanArray (Laser power at 100 % and PMT at 100 %), aminolink
primer produced a spot on the glass plate while no-aminolink primer did not. Aminolink
primer itself does not emit fluorescence, and the spot was due to the rough surface of the
glass plate in the area the primer was spotted. This indicates something on the glass plate
makes the surface rough and this something mu t be the arninolink primer ince no-
aminolink primer did not produced a spot under the same condition .
Next, I attempted PCR amplification on the glass-plate supported ViSA card with
Cy5 and Klentaq. I have never achieved detectable PCR amplification on the silylat d
glass plate. Thus, second possibility (Cy3 incorporation) was not the reason why no
amplification was detected on the glass slide.
ViSH chip results
When Cy5 labeled PCR product was incubated with a primer-attached glass slide
(ViSH chip) at 50°C for overnight, it produced a high background in the inside of the
frame-seal chamber. A similar high background resulted from PCR on the ViSA card.
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-Background problem was solved by applying 1 % blocking reagent on th lid b for
use.
A ViSH chip containing pot of P2 and TS2 primer wa tr at d with 1 %
blocking reagent after primer was immobilized on the lide and w w h d with 0.2 %
SDS solution for 1 minute, and then, with ddH20 for 1 minute twic . Th upper par of
the ViSH chip was incubated at 50°C overnight with Cy5-lab 1 d PCR product formed
by soluble PCR without template, and the lower part was incubated with Cy5-labeled
PCR product made with BVDV-2 template. Fig. 11-1, scanned at 60 % laser power and
50 % PMT, shows the spot in the lower part was stronger than the one in the upper part.
Thus, blocking reagent avoided the attachment of Cy5 or PCR product directly to the
glass slide and PCR product was attached only to the primer. The same result was
acquired from ViSH chip, which was treated with 1 % blocking reagent immediately after
4 hours of rehydration and washing steps. PCR was also performed with blocking reagent
treated ViSA card, but no peR product wa produced on the ViSA card.
I
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-Fig. 11-1 BVDV-2 detection on ViSH chip without UniHyb
Scanned image of glass slide containing P2 and TS2 primers and hybridized in
the presence or absence of Cy5 labeled BVDV-2 product using hybridization
reagent. Arrow marks "A" faint white area which indicates the area covered by
the PCR solution and the Frame-Seal.
Fig. 11-2 BVDV-2 detection on ViSH chip with UniHyb
Scanned image of glass slide containing P2 and TS2 primers and hybridized in
the presence or absence ofCy5 labeled BVDV-2 product using UniHyb. Arrow
marks "A" faint white area which indicates the area covered by the PCR olution
and the Frame-Seal.
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ViSH chip with UniHyb as a hybridization solution
The previous section demonstrated hybridization or annealing of the PCR pr duct
on the ViSH chip without a hybridization solution. Mter that, I tarted to hybridize th
PCR product on the ViSH chip using UniHyb. These ViSH chips howed high r contrast
between positive and negative (no-template) control in hybridization of PCR product than
ViSH chip without UniHyb in Fig. 11-1.
The process to attach primers is the same between two, but the ViSH chip without
using UniHyb was treated with 1 % blocking reagent (Fig. 11-1) and the ViSH chip with
using UniHyb was not treated with blocking reagent prior to use (Fig. 11-2). In one
experiment, 5 JlL Cy5 labeled BVDV-2 PCR product was hybridized to a ViSH chip with
20 JlL UniHyb for 4 hours at 50°C. Fig. 10-2 shows the scanning result of the ViSH chip
with UniHyb. The scanning conditions are same for Fig. 11-1 and Fig. 11-2. The contrast
between positive and no-template control is bigger in the ViSH card with UniHyb (Fig.
I 1-2) than one without UniHyb (Fig. 11-1). The ViSH chip with UniHyb produe d
weaker fluorescence on no-template control and stronger f1uore cence with template than
blocking reagent treated ViSH chip without UniHyb. Thus, the use of UniHyb can make
it easier to identify the virus.
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Fig. 12 BVDV-2 detection on the ViSH chip with 6 different oligonucleotides
From left, image of ViSH chip with oligonucleotide po ition ,no-template
control, BVDV-2 control, and gel electrophoresis result for labeled peR
products. Gel electrophoresi re ult, from left, lane 1 100 bp ladder, BVDV-2
template product, and no-template control.
Next, TS2, TS 1, PI, P2, 665, and 766 were spotted separately on the ViSH chip,
and hybridized with Cy5 labeled BVDV-2 first amplification product for 4 hours at 50°C
(Fig. 12). Since BVDV-2 first amplification product contained P2 and PI primers
sequence at the extremities and the sequence complementary to TS2 primer in the middle
of PCR product, these three produced spots on the ViSH chip. Other primers were not
seen as fluorescent spots on the ViSH chip scanning result. Both no-template control and
BVDV-2 template amplification product contained P2 and P I as PCR primers and less
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than a 100 bp sized product which probably w cau ed by primer dim r formation.
Another chip was hybridized with a Cy5-labeled no-template control amplification
product. This chip produced a pot only on the PI primer. Thi indicat s that artifact or
primer dimer is due only to P I primer. This artifact or primer dimer can be seen in the
soluble peR result as a less than 100 bp product.
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-Conclusions
In this research, I established soluble multiplex peR condition for di tingui hing
between BHV-l and BVDV-2. No diagnostic method using multiplex m thod for
distinguishing between BHV-I and BVDV is publi hed yet. Thi multiplex PCR is u eful
since both BHV-I and BVDV are a major cause of BRD, and the treatment for the herd
will differ depending on the type of virus infection. By using multiplex PCR, in tead of
single template PCR, we can reduce reagent costs as well as possible contamination37.
Although I did not test wider applications, the diagnosis of BHV-I, BVDV-l, BVDV-2,
and BDV will be possible since the multiplex PCR I used included the primer pair for all
the viruses listed above and PCR conditions were set up for all.
As mentioned in the introduction, multiplex PCR for typing BVDV without RNA
extraction has been published 25,26. In my research, r did not perfonn PCR without RNA
extraction for BVDV but it would help to reduce the time for diagnosis to less than 8
h0ur after a blood sample is collected.
Though Multiplex PCR method was established for BHV-I and BVDV, I exp ct
that it will be more difficult to add more viruses for a simultaneous diagno i due to three
reasons (see introduction). Firstly, the PCR product interacts with primer and oth r
products. Secondly, because of various sizes of PCR products, it will be difficult to read
the electrophoresis gel. Lastly, there is the competition among the PCR product. Real-
time PCR is a very fast method and can be automated. However, since there are more
than 13 infectious agents in BRO, real-time PCR must be multiplexed or separated into
13 single virus detections. Thus, I tried to develop the ViSA card method.
A ViSA card can amplify a fragment of virus DNA with immobilized primer sets
and detect the amplified products by chemiluminescence or fluorescence scanning for
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fluorescently labeled product Both bridge amplification technologi ,which w
e tablished by Mosaic Technologies, Inc. and the ViSA card h v : u
of less reagents and the ability to avoid cross-contamination. Howev r, nylon-bas d ViSA
cards can be created more easily and less expensively than bridge amplification
technology which uses acrylamide-modified oligonucleotide immobilized primers.
The ViSA card method uses UV crosslinking or vacuum oven to immobilize prim r on a
nylon membrane. With the ViSA card, I succeeded in detecting all BHV-1, BHV-2,
BVDV-I, and BVDV-2 in single template PCR, and a mixture ofBHV-2 and BVDV-I in
multiplex PCR (all data not shown). Differentiating between BVDV types was uccessful
but it was not entirely satisfactory due to high background (data not shown). The high
background problem was caused by non-specific binding of DIG labeled PCR products to
the primers and the no-primer-attached area. When detecting the type of BVDV, the
BVDV-I peR product bound non-specifically with unexpected primers for BVDV-2
(TS I) and BDV (TS3). All nylon membrane ba ed ViSA card produced high
background levels when primer or virus template concentrations were high. This problem
can be partially solved by reducing the primer or template concentration. I did not
establish the method to determine the optimum concentration of the primer and template
for the ViSA card. It will be take some time to optimize the reaction for nylon membrane-
based ViSA card method. This background problem must be solved before further use of
the ViSA cards can be made.
Glass plate based ViSA card can be scanned with high sensitivity by laser
scanning microscopy. However, amplification efficiency on the gla s plate was extremely
low. It can detect BHV-1, but it was not clear enough compared to the nylon membrane
based ViSA card. This seems to be a common problem when we work with immobilized
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PCR. Boles, T. C. et. al. wrote that the amplification efficiency w 1.2 to 1.3 per cycl in
bridge technologies and about 1.9 per cycle in soluble PCR32. I u ed ilylated gla slide
and borohydride treatment to attach primers on the slide. This method h been u ed for
microarray technologies38 which normally employs hybridization temperature normally
up to 70°C. In the ViSA card method, the temperature is elevated up to 95 °C for the
denaturing step. This high temperature probably broke the bonds between primer and
support. and reduced the amplificat~on efficiency on glass slide supports.
The ViSH chip method showed clearer results compared to the ViSA card. The
ViSH chip with UniHyb hybridized with two out of three BVDV-2 primers and no other
primers when it was incubated with Cy5 labeled BVDV-2 first PCR product. Thi
experiment also revealed that primer-dimer or primer artifacts, which were made during
soluble PCR, were made from PI primer since the ViSH chip reacted only with Pl and
TS2 primers. For the ViSH chip, blocking reagent was essential to reduce background
problems. The ViSH chip without UniHyb and blocking reagent treatment had a much
stronger background than the one with blocking reagent treatment without UniHyb. The
ViSH chip with UniHyb had stronger positive reaction and weaker negative reaction.
Thus, UniHyb will be useful for further experiments. Furthermore, a univer al method to
make Cy labeled PCR products for all 13 viruse that cause BRD to u e the ViSH chip
for diagnosis of BRD is needed. DNA chip technology uses thousands of oligonucleotides
as probes. This is to assure that the detected result is not from unexpected contamination.
It is also useful for the ViSH chip and the ViSA card to make sure the detection of viru
is correct by checking with many sets of oligonucleotide. GenChip technology will be
very useful in constructing the ViSH chip with high density oligonucleotides.
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